Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2

Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence by Targeting SMYD2

Metastatic castration-resistant prostate cancer (mCRPC) is the most aggressive prostate cancer (PC) phenotype. Cellular lysine methylation is driven by protein lysine methyltransferases (PKMTs), such as those in the SET- and MYND-containing protein (SMYD) family, including SMYD2 methylate, and sever...

Full description

Bibliographic Details
Main Authors: Abu Bakar Siddique, Hassan Y. Ebrahim, Afsana Tajmim, Judy Ann King, Khaldoun S. Abdelwahed, Zakaria Y. Abd Elmageed, Khalid A. El Sayed
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
castration-resistant
prostate cancer
extra-virgin olive oil
nutraceutical
oleocanthal
progression
Online Access:https://www.mdpi.com/2072-6694/14/14/3542

Internet

https://www.mdpi.com/2072-6694/14/14/3542

Similar Items